Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Chandrima Sanyal

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk

Pharmacy,,Pills,And,Tablet,With,Hands,Of,Person,For,Medicine,

The U.S. pharmaceutical industry is at the center of a policy maelstrom. President Donald Trump on Sep 25, put a 100% tariff on imported branded and patented medicines starting from Oct 1 with threats that tariffs might go up to as much as 250% in future. The instant market impact was intense: big pharma stocks such as Eli Lilly And Co (NYSE: LLY), Pfizer Inc (NYSE: PFE), and AstraZeneca PLC (NYSE: AZN) fell under pressure initially, pulling pharmaceutical ETFs down.

Also Read: Consumers Splurge, Intel, GlobalFoundries, Lilly, Paccar, American Woodmark Benefit From New Tariffs

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.